Search

everythinglearnresearchcommunity

for

Search:↓

Endoscopic brow-lift is effective and well-tolerated, with high patient satisfaction and improved appearance.

Simpler treatments and better drug delivery improve acne and rosacea outcomes.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

Endoscopic-assisted surgery leads to higher patient satisfaction in breast reconstruction.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

New tools help assess eyebrow, eyelash, and nail changes in Alopecia Areata, improving understanding of patient experiences.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

Hair regrowth in Alopecia Areata patients leads to increased satisfaction and reduced stress.

High-quality validation studies are needed to improve alopecia areata patient-reported outcome measures.

Disease-specific tools better assess alopecia areata's impact on quality of life.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Topical finasteride/minoxidil is effective but not better than oral finasteride for hair loss.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

The cream effectively treats scalp psoriasis, improving symptoms and quality of life, with high patient satisfaction.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

PRP injections improve skin and hair quality, boost self-esteem, and are safe and satisfying for patients.

Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

Patients with multiple superficial venous thrombosis are at greater risk for serious complications like cancer and recurrent blood clots.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.